Protective effect of prolactin and placental lactogen on NO-induced Nb2 lymphoma cell apoptosis

被引:8
作者
Fernández, ML [1 ]
Iglesias, MM [1 ]
Biron, VA [1 ]
Wolfenstein-Todel, C [1 ]
机构
[1] Univ Buenos Aires, Inst Quim & Fisicoquim Biol, CONICET, Fac Farm & Bioquim, RA-1113 Buenos Aires, DF, Argentina
关键词
apoptosis; NO-donors; placental lactogen; prolactin; Nb2 lymphoma cells;
D O I
10.1016/S0003-9861(03)00292-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nitric oxide (NO) is an important modulator involved in immune regulation. Here, we describe conditions under which NO-donors induce apoptosis on Nb2 lymphoma cells, as evidenced by decreased cell viability and increased hypodiploid DNA content determined by flow cytometry. In addition, DNA fragmentation typical of apoptosis was shown by agarose gel electrophoresis. This apoptosis was accompanied by a significant increase of caspase-3-like enzymatic activity. Both ovine prolactin (oPRL) and ovine placental lactogen (oPL) exerted a protective effect on the NO-donor-induced apoptosis. Furthermore, dexamethasone (Dex)-induced cell death was also associated with caspase-3-like activity and oPL had the same potency as oPRL in its protective effect on Dex-induced apoptosis of Nb2 cells. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:249 / 256
页数:8
相关论文
共 55 条
[41]   Bcl-2 protects macrophages from nitric oxide-induced apoptosis [J].
Messmer, UK ;
Reed, JC ;
Brune, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (33) :20192-20197
[42]  
NICOLL CS, 1986, ENDOCR REV, V7, P169, DOI 10.1210/edrv-7-2-169
[43]   Nitric oxide can function as either a killer molecule or an antiapoptotic effector in cardiomyocytes [J].
Stefanelli, C ;
Pignatti, C ;
Tantini, B ;
Stanic, I ;
Bonavita, F ;
Muscari, C ;
Guarnieri, C ;
Clo, C ;
Caldarera, CM .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1999, 1450 (03) :406-413
[44]   A NEW SENSITIVE AND SPECIFIC BIOASSAY FOR LACTOGENIC HORMONES - MEASUREMENT OF PROLACTIN AND GROWTH-HORMONE IN HUMAN-SERUM [J].
TANAKA, T ;
SHIU, RPC ;
GOUT, PW ;
BEER, CT ;
NOBLE, RL ;
FRIESEN, HG .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1980, 51 (05) :1058-1063
[45]  
THORNBERRY NA, 1996, SCIENCE, V281, P1313
[46]  
Tsumori M, 2002, ACTA BIOCHIM POL, V49, P139
[47]   Nitric oxide-induced apoptosis in tumor cells [J].
Umansky, V ;
Schirrmacher, V .
ADVANCES IN CANCER RESEARCH, VOL 82, 2001, 82 :107-131
[48]   Nitric oxide-induced apoptosis in human leukemic lines requires mitochondrial lipid degradation and cytochrome C release [J].
Ushmorov, A ;
Ratter, F ;
Lehmann, V ;
Dröge, W ;
Schirrmacher, V ;
Umansky, V .
BLOOD, 1999, 93 (07) :2342-2352
[49]   Prolactin, growth hormone and the immune system in humans [J].
Velkeniers, B ;
Dogusan, Z ;
Naessens, F ;
Hooghe, R ;
Hooghe-Peters, EL .
CELLULAR AND MOLECULAR LIFE SCIENCES, 1998, 54 (10) :1102-1108
[50]   PURIFICATION AND STRUCTURAL CHARACTERIZATION OF OVINE PLACENTAL-LACTOGEN [J].
WARREN, WC ;
LIANG, R ;
KRIVI, GG ;
SIEGEL, NR ;
ANTHONY, RV .
JOURNAL OF ENDOCRINOLOGY, 1990, 126 (01) :141-149